Unleashing cGMP Manufacturing in Biotech: Strategic Insights and Resources from Argonaut
As we wrap up 2023 and look ahead to 2024, the biotech industry reflects on a challenging year behind us marked by the aftermath of
As we wrap up 2023 and look ahead to 2024, the biotech industry reflects on a challenging year behind us marked by the aftermath of
… but things may be looking up. Marketplace Podcast, Interview With CEO Wayne Woodard Public media podcast, Marketplace, delves into the intricate responses of manufacturing
Argonaut Manufacturing Services in a Molecule to Market Podcast Episode In the podcast series Molecule to Market, Raman Sehgal interviews influential leaders in the biopharmaceutical
What can we learn from last year’s biotech/pharma manufacturing As the JPM meeting of 2023 closes, what can we learn from the last year and
Updated October 16, 2022 In 2008-2010, the economic downturn in biotech wreaked havoc on the unprepared industry. Fast forward to late 2022, and the economic
Opinion: Wayne Woodard, CEO Argonaut Manufacturing Services Molecular Diagnostic Manufacturing in USA In early September 2020, I wrote an opinion piece titled “Bring Manufacturing Back
EUA Status for COVID-19 – Getting Back to Normal Operations The FDA recently recommended that “manufacturers of devices authorized under EUA’s (to) plan now, while
We made it happen. We brought back our Oktoberfest Annual Open House and a grand time was had. It felt incredible to meet with our
As the Fourth of July approaches and we celebrate Independence Day, there is a renewed optimism in the air that the worst of the pandemic
What are the challenges when manufacturing controls? As an assay developer, you understand the importance of having quality controls and standards for your assay, but